Our data suggest that although both CD4‐to‐CD8 and neutrophil‐to‐CD8 ratios are predictive of in‐ICU mortality of severe COVID‐19 cases ICU, the former appears to have stronger predictive potential as it remains stable throughout treatment in survivors. The gene discussed is CD4; the disease is COVID-19.